Pyrrole or imidazole amides for treating obesity

Details for Australian Patent Application No. 2005240734 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Roever, Stephan; Narquizian, Robert; Mayweg, Alexander; Pflieger, Philippe

Agent Spruson & Ferguson

Pub. Number AU-A-2005240734

PCT Pub. Number WO2005/108393

Priority 04102005.8 10.05.04 EP

Filing date 25 April 2005

Wipo publication date 17 November 2005

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/108393 Priority application(s): WO2005/108393

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240738-Push-pull chain and actuator

2005240733-Novel beta agonists, method for producing the same and their use as drugs